Figure 2.
Kaplan–Meier estimates OS according to the ALBI score in both training cohort (A) and validation cohort (B). In the training cohort and validation cohort, the median OS in patients with a pretreatment ALBI >−2.6 was significantly shorter than those of patients with a ALBI <−2.6. ALBI = albumin-bilirubin, OS = overall survival.